Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR)

CUSIP: 92764N102

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
168,432,200
Total 13F shares
86,118,572
Share change
-873,629
Total reported value
$2,179,650,166
Put/Call ratio
49%
Price per share
$25.31
Number of holders
219
Value change
-$15,704,818
Number of buys
107
Number of sells
97

Security key

92764N102

Report period

Q4 2022

Institutions

219

Top holders

10

Top shareholders of VIR - Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
SB INVESTMENT ADVISERS (UK) LTD
13F
Company
13%
22,086,280
$425,823,000 30 Sep 2022
13F
BlackRock Finance, Inc.
13F
Company
8.2%
13,873,726
$267,486,000 30 Sep 2022
13F
VANGUARD GROUP INC
13F
Company
5.9%
9,928,416
$191,420,000 30 Sep 2022
13F
Temasek Holdings (Private) Ltd
13F
Company
3.6%
6,036,821
$116,389,909 30 Sep 2022
13F
STATE STREET CORP
13F
Company
3.5%
5,830,417
$112,410,000 30 Sep 2022
13F
BAILLIE GIFFORD & CO
13F
Company
2.4%
3,978,657
$76,709,000 30 Sep 2022
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
1.4%
2,334,318
$45,006,000 30 Sep 2022
13F
Gates Foundation
13F
Company
0.93%
1,559,142
$30,100,000 30 Sep 2022
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.9%
1,512,494
$29,161,000 30 Sep 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.84%
1,416,229
$27,304,000 30 Sep 2022
13F
MORGAN STANLEY
13F
Company
0.68%
1,145,658
$22,088,000 30 Sep 2022
13F
NORTHERN TRUST CORP
13F
Company
0.49%
830,664
$16,015,000 30 Sep 2022
13F
Bank of New York Mellon Corp
13F
Company
0.43%
730,087
$14,077,000 30 Sep 2022
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.41%
688,782
$13,280,000 30 Sep 2022
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.39%
651,373
$12,559,000 30 Sep 2022
13F
NORGES BANK
13F
Company
0.37%
615,867
$11,873,916 30 Sep 2022
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.34%
577,377
$11,132,000 30 Sep 2022
13F
Nuveen Asset Management, LLC
13F
Company
0.34%
566,381
$10,919,000 30 Sep 2022
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.33%
560,321
$10,803,000 30 Sep 2022
13F
Invesco Ltd.
13F
Company
0.3%
505,946
$9,755,000 30 Sep 2022
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.29%
480,746
$9,268,000 30 Sep 2022
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.26%
436,087
$8,408,000 30 Sep 2022
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.23%
385,609
$7,436,000 30 Sep 2022
13F
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
0.23%
385,146
$7,426,000 30 Sep 2022
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.21%
352,733
$6,801,000 30 Sep 2022
13F
MARSHALL WACE, LLP
13F
Company
0.21%
346,276
$6,678,000 30 Sep 2022
13F
CITIGROUP INC
13F
Company
0.19%
318,760
$6,146,000 30 Sep 2022
13F
CAPITAL FUND MANAGEMENT S.A.
13F
Company
0.19%
314,631
$6,066,085 30 Sep 2022
13F
Rafferty Asset Management, LLC
13F
Company
0.18%
309,577
$5,969,000 30 Sep 2022
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.17%
289,170
$5,575,000 30 Sep 2022
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.15%
260,717
$5,027,000 30 Sep 2022
13F
Capital International Investors
13F
Company
0.15%
258,400
$4,982,000 30 Sep 2022
13F
BARCLAYS PLC
13F
Company
0.14%
239,488
$4,617,000 30 Sep 2022
13F
FEDERATED HERMES, INC.
13F
Company
0.14%
237,913
$4,587,000 30 Sep 2022
13F
RHUMBLINE ADVISERS
13F
Company
0.13%
222,367
$4,287,000 30 Sep 2022
13F
Legal & General Group Plc
13F
Company
0.13%
218,438
$4,212,000 30 Sep 2022
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.12%
199,417
$3,843,000 30 Sep 2022
13F
CLARK ESTATES INC/NY
13F
Company
0.11%
180,000
$3,470,000 30 Sep 2022
13F
Swiss National Bank
13F
Company
0.1%
172,600
$3,328,000 30 Sep 2022
13F
TWINBEECH CAPITAL LP
13F
Company
0.1%
165,460
$3,190,000 30 Sep 2022
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.1%
164,384
$3,169,000 30 Sep 2022
13F
Man Group plc
13F
Company
0.1%
161,239
$3,109,000 30 Sep 2022
13F
NORDEA INVESTMENT MANAGEMENT AB
13F
Company
0.09%
153,460
$2,980,000 30 Sep 2022
13F
FIRST TRUST ADVISORS LP
13F
Company
0.09%
146,993
$2,834,000 30 Sep 2022
13F
PUBLIC SECTOR PENSION INVESTMENT BOARD
13F
Company
0.08%
138,583
$2,672,000 30 Sep 2022
13F
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
13F
Company
0.08%
130,409
$2,514,000 30 Sep 2022
13F
CITADEL ADVISORS LLC
13F
Company
0.07%
121,960
$2,351,000 30 Sep 2022
13F
Ensign Peak Advisors, Inc
13F
Company
0.06%
106,840
$2,060,000 30 Sep 2022
13F
Trexquant Investment LP
13F
Company
0.06%
106,800
$2,059,000 30 Sep 2022
13F
Cubist Systematic Strategies, LLC
13F
Company
0.06%
105,507
$2,034,000 30 Sep 2022
13F

Institutional Holders of Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR) as of Q4 2022

As of 31 Dec 2022, Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR) was held by 219 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 86,118,572 shares. The largest 10 holders included SB INVESTMENT ADVISERS (UK) LTD, BlackRock Inc., VANGUARD GROUP INC, Temasek Holdings (Private) Ltd, STATE STREET CORP, BAILLIE GIFFORD & CO, ALLIANCEBERNSTEIN L.P., Bill & Melinda Gates Foundation, GEODE CAPITAL MANAGEMENT, LLC, and MORGAN STANLEY. This page lists 220 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders
208
Q4 2022 holders
219
Holder diff
11
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 Value $ Q4 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .